Images List Premium Download Classic

Diabetes

Diabetes-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Assays and reagents for diagnosing type 1 diabetes
L2 Diagnostics, Llc
July 12, 2018 - N°20180195125

Described herein are compositions and methods for diagnosing or monitoring type 1 diabetes.. .
Substrate selective inhibitors of insulin degrading enzyme (ide) and uses thereof
President And Fellows Of Harvard College
July 12, 2018 - N°20180194768

Provided herein are compounds of formulae (rl), (i), (ii), (iii), (iv), and (v), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, prodrugs, and isotopically labeled derivatives thereof. Also provided are pharmaceutical compositions, kits, and methods involving the inventive compounds for the treatment of metabolic disorders (e.g., diabetes, hyperglycemia, impaired glucose tolerance, insulin resistance, obesity).
Tetrahydropyranyl benzamide derivatives
July 12, 2018 - N°20180194755

Wherein r, r1-r3 are as described herein; methods of treating patients for diabetes using the compounds, and processes for preparing the compounds. .
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of delivering subliminal messages
July 12, 2018 - N°20180193587

This invention relates to a method of delivering subliminal messages to a user for providing positive benefits by using the subliminal programming app. The frequencies of the subliminal messages are such that which cannot be heard by human ear.
Pharmaceutical composition, methods for treating and uses thereof
Boehringer Ingelheim International Gmbh
July 12, 2018 - N°20180193427

The invention relates to a pharmaceutical composition according to the claim 1 comprising an sglt2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and ...
Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof
The University Of British Columbia
July 12, 2018 - N°20180193413

Provided are methods, uses and pharmaceutical compositions for inhibition of mammalian alpha-amylase in a subject, with a helianthamide peptide or a derivative thereof in a biologically effective amount. The subject in need of alpha-amylase inhibition, may have or be at risk of developing one or more of the following: middleton syndrome; a motility disorder of the gastrointestinal tract; postprandial reactive ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in ...
The Regents Of The University Of California
July 12, 2018 - N°20180193295

In certain embodiments methods are provided for the therapeutic or prophylactic amelioration of one or more symptoms or disorders associated with metabolic syndrome. In various embodiments the methods involve administering to a subject in need thereof, a gaba receptor agonist, in an amount sufficient to ameliorate said one or more symptoms.
Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same
Concordia University
July 12, 2018 - N°20180193286

Compositions and pharmaceutical compositions including a dendrimer-resveratrol complex and methods for making and using the compositions are described herein. Methods of treating cancer, cardiovascular disease, cardiac failure, diabetes, alzheimer's disease, parkinson's disease and other brain diseases, fatty liver disease, obesity, cataracts, osteoporosis, muscle wasting, sleep disorders, acoustic trauma, inflammatory disease, psoriasis, arthritis, colitis, aging, viral disease, reproductive disease, and skin ...
Nano-liposome carrier composition containing hybrid of cas9 protein and guide rna
Moogene Medi Co. Ltd.
July 12, 2018 - N°20180193269

The present invention relates to nano-liposome carrier compositions that encapsulate a hybrid of a cas9 protein and a guide rna and methods of making and using the same. The nano-liposome carrier compositions have an excellent effect of suppressing expression of target dna, and thus pharmaceutical compositions including the nano-liposome carrier compositions can be used for treating diseases such as diabetes..
Devices and methods for the treatment of tissue
Fractyl Laboratories Inc.
July 12, 2018 - N°20180193078

Systems, methods and devices for the treatment of tissue are disclosed. A system includes an elongate tube with a distal portion.
Antibodies that bind to tl1a and methods of treating inflammatory or autoimmune disease comprising ...
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services
July 05, 2018 - N°20180186888

Methods and compositions for treating inflammatory or autoimmune diseases in a subject comprising blocking the interaction between dr3 and tl1a. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be an autoimmune disease with a t cell component, including asthma, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, graft versus host disease or inflammatory bowel ...
Treating type i and type ii diabetes
Mayo Foundation For Medical Education And Research
July 05, 2018 - N°20180186854

This document provides methods and materials for treating diabetes. For example, methods and materials for using nucleic acid encoding human preproinsulin to treat diabetes (e.g., type i or type ii diabetes) are provided..
Chimeric fibroblast growth factor 19 proteins and methods of use
New York University
July 05, 2018 - N°20180186850

The present invention relates to a chimeric protein that includes an n-terminus coupled to a c-terminus, where the n-terminus includes a portion of a paracrine fibroblast growth factor (“fgf”) and the c-terminus includes a c-terminal portion of an fgf19 molecule. The portion of the paracrine fgf is modified to decrease binding affinity for heparin and/or ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
Glaxosmithkline Llc
July 05, 2018 - N°20180186801

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, ...
5-ht2c receptor agonists and compositions and methods of use
Arena Pharmaceuticals, Inc.
July 05, 2018 - N°20180186797

Provided in some embodiments are compounds herein. Also provided in some embodiments are methods for weight management, inducing satiety, and decreasing food intake, and for preventing and treating obesity, antipsychotic-induced weight gain, type 2 diabetes, prader-willi syndrome, tobacco/nicotine dependence, drug addiction, alcohol addiction, pathological gambling, reward deficiency syndrome, and sex addiction), obsessive-compulsive spectrum disorders and impulse control disorders (including nail-biting ...
Leukocyte and microparticles fractionation using microfluidics
Nanyang Technological University
July 05, 2018 - N°20180185846

This invention relates to a method for separating blood cells comprising the steps of: (a) lysing red blood cells of a blood sample and diluting said sample; (b) providing a microfluidic device comprising a spiral-shaped flow channel having at least a first end and a second end, wherein said flow channel has two inlet ports at or near said first ...
Method of treating diabetes type 2 by administering ultrarapid acting insulin
Mannkind Corporation
July 05, 2018 - N°20180185453

Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.. .
Exendin-4 derivatives as dual glp1/glucagon agonists
Sanofi
July 05, 2018 - N°20180185450

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.. .
Synthetic composition for microbiota modulation
Glycom A/s
July 05, 2018 - N°20180185396

A human milk oligosaccharide (hmo) or a synthetic composition comprising said hmo, for use in increasing the abundance, particularly the relative abundance, of a bifidobacterium of the b. Adolescentis phylogenic group in the microbiota in the gastro-intestinal tract of a human, preferably a non-infant human.
Compositions and methods for diagnosis and treatment of inflammation
The United States Of America As Represented By The Secretary Of The Navy
July 05, 2018 - N°20180185316

Compositions including an fatty acid, such as an odd chain fatty acid or a very long even chain fatty acid, and salts and derivatives thereof, and methods for treatment and prophylaxis of conditions related to inflammation and conditions related to inflammation, including anemia of chronic disease, insulin resistance, metabolic syndrome, autoimmune disease, hypertension, diabetes, nonalcoholic fatty liver disease, cardiovascular disease, ...
Compositions and methods for treating neurological diseases or injury
Musc Foundation For Research Development
July 05, 2018 - N°20180185306

Provided are compounds for the treatment of neurological diseases or injuries, including neurodegenerative diseases, stroke, trauma, epilepsy, acute and chronic kidney injuries, diabetes mellitus, and/or seizures. In some embodiments, derivatives of vitamin k are provided..
Loading